myrtenal has been researched along with Arthritis, Rheumatoid in 1 studies
*Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Gu, L; Guo, YT; Jurat, J; Li, WX; Qian, P; Zhang, DF | 1 |
1 other study(ies) available for myrtenal and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Myrtenal and β-caryophyllene oxide screened from Liquidambaris Fructus suppress NLRP3 inflammasome components in rheumatoid arthritis.
Topics: Animals; Arthritis, Rheumatoid; Bicyclic Monoterpenes; Inflammasomes; Male; Molecular Docking Simulation; Network Pharmacology; NLR Family, Pyrin Domain-Containing 3 Protein; Polycyclic Sesquiterpenes; Rats; Rats, Inbred WF | 2021 |